These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

883 related articles for article (PubMed ID: 17626986)

  • 1. Home therapy with LMWH in deep vein thrombosis: randomized study comparing single and double daily administrations.
    Bellosta R; Ferrari P; Luzzani L; Carugati C; Cossu L; Talarico M; Sarcina A
    Angiology; 2007; 58(3):316-22. PubMed ID: 17626986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evolution in the pharmacological treatment of venous thrombosis according to evidence-based medicine].
    Manganaro A; Giannino D; Lembo D; Bruni F; Consolo F
    Minerva Cardioangiol; 2000 Dec; 48(12 Suppl 1):41-51. PubMed ID: 11253339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of low-molecular-weight heparin, administered primarily at home, with unfractionated heparin, administered in hospital, and subcutaneous heparin, administered at home for deep-vein thrombosis.
    Belcaro G; Nicolaides AN; Cesarone MR; Laurora G; De Sanctis MT; Incandela L; Barsotti A; Corsi M; Vasdekis S; Christopoulos D; Lennox A; Malouf M
    Angiology; 1999 Oct; 50(10):781-7. PubMed ID: 10535716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregnancy after catheter-directed thrombolysis for acute iliofemoral deep venous thrombosis.
    Jørgensen M; Broholm R; Bækgaard N
    Phlebology; 2013 Mar; 28 Suppl 1():34-8. PubMed ID: 23482532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low molecular weight heparin versus oral anticoagulants in the long-term treatment of deep venous thrombosis.
    López-Beret P; Orgaz A; Fontcuberta J; Doblas M; Martinez A; Lozano G; Romero A
    J Vasc Surg; 2001 Jan; 33(1):77-90. PubMed ID: 11137927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total knee replacement: prevention of deep-vein thrombosis using pharmacological (low-molecular-weight heparin) and mechanical (intermittent foot sole pump system) combined prophylaxis. Preliminary results.
    Giannoni MF; Ciatti R; Capoccia L; Ruggiero M; Dauri M; Mariani PP
    Int Angiol; 2006 Sep; 25(3):316-21. PubMed ID: 16878083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Home treatment of deep venous thrombosis with low molecular weight heparin: Long-term incidence of recurrent venous thromboembolism.
    Grau E; Tenias JM; Real E; Medrano J; Ferrer R; Pastor E; Selfa S
    Am J Hematol; 2001 May; 67(1):10-4. PubMed ID: 11279651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapy of isolated calf muscle vein thrombosis: a randomized, controlled study.
    Schwarz T; Buschmann L; Beyer J; Halbritter K; Rastan A; Schellong S
    J Vasc Surg; 2010 Nov; 52(5):1246-50. PubMed ID: 20630682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
    Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H
    Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Major bleeding risks of different low-molecular-weight heparin agents: a cohort study in 12 934 patients treated for acute venous thrombosis.
    van Rein N; Biedermann JS; van der Meer FJM; Cannegieter SC; Wiersma N; Vermaas HW; Reitsma PH; Kruip MJHA; Lijfering WM
    J Thromb Haemost; 2017 Jul; 15(7):1386-1391. PubMed ID: 28440008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulant therapy for symptomatic calf deep vein thrombosis (CACTUS): a randomised, double-blind, placebo-controlled trial.
    Righini M; Galanaud JP; Guenneguez H; Brisot D; Diard A; Faisse P; Barrellier MT; Hamel-Desnos C; Jurus C; Pichot O; Martin M; Mazzolai L; Choquenet C; Accassat S; Robert-Ebadi H; Carrier M; Le Gal G; Mermilllod B; Laroche JP; Bounameaux H; Perrier A; Kahn SR; Quere I
    Lancet Haematol; 2016 Dec; 3(12):e556-e562. PubMed ID: 27836513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized double-blind study of low-molecular-weight heparin (parnaparin) for superficial vein thrombosis: STEFLUX (Superficial ThromboEmbolism and Fluxum).
    Cosmi B; Filippini M; Tonti D; Avruscio G; Ghirarduzzi A; Bucherini E; Camporese G; Imberti D; Palareti G;
    J Thromb Haemost; 2012 Jun; 10(6):1026-35. PubMed ID: 22487001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of a low molecular weight heparin administered intravenously or subcutaneously in comparison with intravenous unfractionated heparin in the treatment of deep venous thrombosis. Certoparin-Study Group.
    Kirchmaier CM; Wolf H; Schäfer H; Ehlers B; Breddin HK
    Int Angiol; 1998 Sep; 17(3):135-45. PubMed ID: 9821025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The development of persistent thrombotic masses in patients with deep venous thrombosis randomized to long-term anticoagulation treatment.
    Vítovec M; Golán L; Roztocil K; Linhart A
    Vasa; 2009 Aug; 38(3):238-44. PubMed ID: 19736635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Out of hospital treatment with subcutaneous low molecular weight heparin in patients with acute deep-vein thrombosis: a prospective study in daily practice.
    Zidane M; van Hulsteijn LH; Brenninkmeijer BJ; Huisman MV
    Haematologica; 2006 Aug; 91(8):1052-8. PubMed ID: 16885045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low molecular weight heparin versus acenocoumarol in the secondary prophylaxis of deep vein thrombosis.
    Lopaciuk S; Bielska-Falda H; Noszczyk W; Bielawiec M; Witkiewicz W; Filipecki S; Michalak J; Ciesielski L; Mackiewicz Z; Czestochowska E; Zawilska K; Cencora A
    Thromb Haemost; 1999 Jan; 81(1):26-31. PubMed ID: 9974369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deep venous thrombosis and pulmonary embolism. Part 1. Initial treatment: usually a low-molecular-weight heparin.
    Prescrire Int; 2013 Apr; 22(137):99-101, 103-4. PubMed ID: 23662321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolated distal deep vein thrombosis: efficacy and safety of a protocol of treatment. Treatment of Isolated Calf Thrombosis (TICT) Study.
    Parisi R; Visonà A; Camporese G; Verlato F; Lessiani G; Antignani PL; Palareti G
    Int Angiol; 2009 Feb; 28(1):68-72. PubMed ID: 19190559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fixed-dose, body weight-independent subcutaneous LMW heparin versus adjusted dose unfractionated intravenous heparin in the initial treatment of proximal venous thrombosis. EASTERN Investigators.
    Harenberg J; Schmidt JA; Koppenhagen K; Tolle A; Huisman MV; Büller HR
    Thromb Haemost; 2000 May; 83(5):652-6. PubMed ID: 10823256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term treatment of deep venous thrombosis with a low molecular weight heparin (tinzaparin): a prospective randomized trial.
    Daskalopoulos ME; Daskalopoulou SS; Tzortzis E; Sfiridis P; Nikolaou A; Dimitroulis D; Kakissis I; Liapis CD
    Eur J Vasc Endovasc Surg; 2005 Jun; 29(6):638-50. PubMed ID: 15878544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.